30301790 |
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
Cutler, RE,
Papadopoulos, KP,
Loi, S,
Avogadri-Connors, F,
Javier Carmona, F,
Scaltriti, M,
Soong, J,
Boni, V,
Bryce, RP,
Baselga, J,
Chan, C,
Toska, E,
Chandarlapaty, S,
Savas, P,
Montemurro, F,
Cownie, J,
Cai, Y,
Moriarty, A,
Cocco, E,
Razavi, P,
Rossi, V,
Lalani, AS,
Berger, MF,
Shifman, SG,
Solit, DB,
Wick, MJ,
Won, HH,
Hyman, DM,
Sarotto, I
|
Sci Signal |
2018 |
23220880 |
Activating HER2 mutations in HER2 gene amplification negative breast cancer
Bose, R,
Shen, W,
Aronson, AB,
Goel, N,
Koboldt, DC,
Li, S,
Searleman, AC,
Ma, CX,
Ellis, MJ,
Shen, D,
Ding, L,
Monsey, J,
Mardis, ER,
Kavuri, SM
|
Cancer Discov |
2013 |